"As per the Gazette notification G.S.R. 918(E), published by Government of India on 30th November, 2015, which underlines the new category namely “Phytopharmaceutical Drug” includes purified and standardised fraction with defined minimum four bio-active or phyto-chemical compounds (qualitatively and quantitatively assessed) of an extract of a medicinal plant or its part, for internal or external use of human beings or animals for diagnosis, treatment, mitigation or prevention of any disease or disorder but does not include administration by parenteral route.’
In the support to this developmental regimen, Herbal Products and Phytopharmaceuticals Monograph Development Subcommittee of IPC, in their second meeting held on 16.10.2019, at IPC, Ghaziabad, recommended to develop the Phytopharmaceutical Ingredient (PPI) category monograph with the support of stakeholders.
In this regard a draft monograph for PPI Category is invited from the stakeholders where defined minimum four bio-active or phyto-chemical compounds (qualitatively and quantitatively assessed) are available in that particular.
Those stakeholders (Relevant industries/Research Institutes/Academic Institutions/Faculties/